Vorinostat
A recent study suggested that vorinostat also possesses some activity against recurrent glioblastoma multiforme, resulting in a median overall survival of 5.7 months (compared to 4–4.4 months in earlier studies). Further brain tumor trials are planned in which vorinostat will be combined with other drugs.
Radiation effects from the Fukushima Daiichi nuclear disaster
Thyroid cancer is one of the most survivable cancers, with an approximate 94% survival rate after first diagnosis, and that rate increases to a 100% survival rate with catching it early. For example, from 1989 to 2005, an excess of 4000 children and adolescent cases of thyroid cancer were observed in those who lived around Chernobyl; of these 4000 people, nine have died so far, a 99% survival rate.